Please enable JS

Finance & Investment (Pharma & Healthcare)

Title Published Pages Region Price
Global Respiratory Syncytial Virus Partnering 2012-2018 Sep 1 2018 150 Global $1,995.00
Global Congestive Heart Failure Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Asthma Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 500 Global $2,995.00
Global Cystic Fibrosis Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Leukemia Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Age-related Macular Degeneration Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts Sep 1 2018 200 Global $2,995.00
Global Neuropathy Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 1000 Global $2,995.00
Global Allergy Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Human Papilloma Virus Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Hypertension Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Smoking Cessation Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Autoimmune Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 700 Global $2,995.00
Global Ulcerative Colitis Partnering 2012-2018 Sep 1 2018 150 Global $1,995.00
Global Gastric Cancer Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Musculoskeletal Symptoms Partnering 2012-2018 Sep 1 2018 100 Global $1,995.00
Global Parkinson's Disease Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Viral Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 500 Global $2,995.00
Global Systemic Lupus Erythematosus Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players May 4 2018 140 Global $2,995.00
Acne Vulgaris - Epidemiology Forecast to 2026 Mar 1 2018 37 Global $3,995.00
OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 Dec 31 2017 195 Global $10,995.00
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 Dec 20 2017 280 Global $10,995.00
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 Dec 20 2017 185 Global $10,995.00
Warner Chilcott Partnering Deals and Alliances 2010 to 2017 Sep 1 2017 100 Global $1,495.00
Global Injectable Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts Sep 1 2017 230 Global $1,995.00
Global Hepatitis Partnering 2010 to 2017 Sep 1 2017 150 Global $1,495.00
Fresenius Partnering Deals and Alliances 2010 to 2017 Sep 1 2017 100 Global $1,495.00

Pages